Karaman Training and Research Hospital
Karaman, 70200, Turkey (Türkiye)
NCT Number: NCT05694676
Depression and anxiety symptoms are common during pregnancy which may disturb the intrauterine environment by affecting the mother's physiological responses to stress, and ultimately impair fetal and postnatal development. There is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. The neurological footprints of these structural changes on the young brain may be caught early in life by a video assessment of General Movements (GMs) quality.
Looking for future studies?
Notify Me10 week–20 week
All sexes
Observational
Karaman, 70200, Turkey (Türkiye)
Depression and anxiety symptoms are common during pregnancy and are estimated to affect 7% - 20% of pregnant women, constituting significant risks for mothers and babies. Depression and anxiety may disturb the intrauterine environment by affecting the mother's physiological responses to stress, and ultimately impair fetal and postnatal development. Increasing evidence shows that prenatal exposure to maternal depression and anxiety is associated with several lifelong adverse outcomes in children, including physical health problems, emotional and behavioral difficulties, and low verbal IQ.
Such maladaptive outcomes are thought to have a neurobiological basis and there is increasing evidence about the effects of maternal distress on young brain tissue leading to some structural changes. However, what is more important is that the neurological footprints of these structural changes on the young brain can be caught early in life. The neurological status of infants can be determined early in life by video assessment of General Movements (GMs) quality. In this study at the age of 3 months, a video assessment of the quality of GMs will be performed to evaluate neurologic conditions.
Only the study team can determine whether someone qualifies for participation.
Mothers Inclusion Criteria:
Infant inclusionary criteria:
Mothers Exclusion Criteria:
Infant exclusion criteri:
The variation, complexity and fluency of movements over a video recording is done and the quality of GMs is classified as normal-optimal, normal-suboptimal, mildly abnormal, and definitely abnormal movements.
Other names: Prechtl's General movements (GMs)
The scale consists of 20 items in total and provides a four-point Likert type measurement (1- anxiety symptom is not present, 4- the symptom lasts all the time). Scores range from 20 (low anxiety) to 80 (high anxiety).
BDI contains 21 items and rates the depressive symptoms for the last week. Each item has four options and is scored between 0 and 3. The total score ranges from 0 to 63. Higher scores indicate more severe depression
Time frame: 3-5 months
Univariate statistical analyses will be performed to calculate differences in mothers' STAI-T scores between children with normal and abnormal GMs.
Time frame: 3-5 months
Univariate statistical analyses will be performed to calculate differences in mothers' BDI scores between children with normal and abnormal GMs.
Time frame: 3-5 months
Significant primary outcome measures will be controlled with:
Karamanoğlu Mehmetbey University
Other
Relationship Between Prenatal Maternal Depression and Anxiety and the Quality of General Movements of Healthy Term Infants at 3 Months
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02813889
Brain Damage, Chronic, Brain Diseases
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT06531330
Brain Damage, Chronic, Brain Diseases
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT02593825
Brain Damage, Chronic, Brain Diseases
Pittsburgh, Pennsylvania, United States
View Trial DetailsNCT05217186
Brain Damage, Chronic, Brain Diseases
Kahramanmaraş, Dulkadiroglu, Turkey (Türkiye)
View Trial Details